Tag: PIQ

Proteomics ASX PIQ Spain Europe PromarkerD diabetic kidney disease test

Proteomics commences European campaign to advance PromarkerD diabetic kidney disease test

Proteomics International Laboratories (ASX: PIQ) has embarked on a European commercialisation campaign following the launch of PromarkerD – its predictive diagnostic test for diabetic...
Proteomics International ASX PIQ Janssen Research & Development PromarkerD pharma diabetes

Proteomics signs collaborate agreement with US pharma giant to advance PromarkerD

Medical technology company Proteomics International Laboratories (ASX: PIQ) has advanced the application of its ground-breaking predictive diagnostic test, PromarkerD, by signing a research collaboration agreement...
Proteomics International Laboratories PromarkerD platform ASX PIQ immunoassay kits kidney disease

Proteomics advances PromarkerD platform and prepares to ship first batch of immunoassay kits

Medical technology company Proteomics International Laboratories (ASX: PIQ) has hatched plans to distribute the first commercial batches of its new “PromarkerD” immunoassay kits, with...
Proteomics ASX PIQ diabetic kidney disease test Spain Patia Europe PromarkerD

Proteomics secures deal to market diabetic kidney disease test in Spain

Proteomics International Laboratories (ASX: PIQ) has clinched a licence deal to market its diabetic kidney disease prediction test in Spain, where around 3.6 million...
Proteomics International ASX PIQ cash flow positive status

Proteomics focuses on analytics and advances towards cash flow positive status

Proteomics International Laboratories (ASX: PIQ) has secured a major commercial contract which propels the company into “nearing” cash flow positive status. Earlier this morning, the...
Proteomics International Laboratories ASX PIQ PromarkerD diabetes detection United States

Proteomics’ predictive diabetes test to be sold in US and could soon be coming to Australia

Medical technology company Proteomics International Laboratories (ASX: PIQ) has announced a significant commercial development this morning with the news that its novel predictive diagnostics...

Proteomics International clinches EU patent for ‘breakthrough’ kidney disease test

Proteomics International (ASX: PIQ) has cemented its commercial ownership rights in Europe for its “breakthrough” diabetic kidney disease prediction test through to 2031, after...
Proteomics International Dimerix ASX PIQ DXB kidney disease

Proteomics International and Dimerix join forces to combat kidney disease

Medical technology company Proteomics International (ASX: PIQ) has teamed up with biotech stock Dimerix (ASX: DXB) to investigate the potential of their combined technology...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS